We would soon like to invite you to take part in our survey. The survey aims to investigate how GPs assess the benefits of biomarkers for GP care. It is already possible to detect biological correlates of Alzheimer’s disease in patients with mild cognitive impairment or even before the onset of cognitive symptoms using minimally invasive blood-based Alzheimer’s biomarkers.
Your GP perspective is important to assess how these new biomarkers can be integrated into care in a meaningful, efficient and ethical way and what support you would like to receive. In a response time of approximately 20 minutes, you will help to understand the current situation, assess technologies and improve the care of people with early memory impairment or concerns.
Your information will of course be treated confidentially and processed anonymously. Participation is voluntary and you can withdraw at any time without consequences. You will also receive a mini-glossary of terms that may require explanation in the questionnaire.
Thank you very much for your time and effort!
If you have any questions or would like further information about the survey, please do not hesitate to contact us.
You can reach our project team member Gamze Altas-Trippler at gamze.altas@dzne.de.